← Evidence map

ArticleeLife2024

DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers.

Jose Mario Bello Pineda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38829686